Project T2
a Technology Transfer Conference

November 13, 2003
Millennium Biltmore Hotel, Los Angeles

Register Now at http://www.Larta.org/t2/

Project T2 is a national conference on technology transfer: the business of turning research into profit. Learn from corporate leaders, investors, and university representatives about issues and trends in technology transfer. Get access to the latest and most revolutionary university spinouts and technologies. Watch hand selected and mentored bioscience and engineering companies from over ten leading universities give investor presentations. Discover ways to form research partnerships and navigate the Southern California University campuses.

Fast Forward 3 weeks...

Featured Speakers

BRIAN ATWOOD
Co-Founder, Versant Ventures

Brian Atwood co-founded Versant Ventures after spending four years at Brentwood Venture Capital, where as a general partner he led investments in biotechnology, pharmaceuticals and bioinformatics. He also has more than 15 years of operating experience in the biotechnology industry, with emphasis on therapeutic products, devices, diagnostics and research instrumentation. Prior to launching his career in venture capital, Brian was founder, president and CEO of Glycomed, a publicly traded biotechnology company.

"Our business as VC's is unearthing technology and innovators at the laboratory level, a process that often bypasses the technology transfer office until it's time to arrange a transfer license. We define the products and then identify the customers and their demand for the products."

"As a venture investor, our preference is emerging and early stage innovation, but beyond the idea stage, with some demonstration of technical feasibility. More than anything else market size, where new markets are being created, envisioning a large market opportunity, and then realizing the opportunity, is the most important success factor."

LARRY GUIHEEN
President, BioPharmaceuticals, Baxter BioSciences

Larry Guiheen is President, BioPharmaceuticals with global responsibility for Sales and Marketing of Baxter’s BioScience (formerly known as Hyland Immuno) Plasma and Recombinant therapies. Prior to his current, position Mr. Guiheen was president of the Hyland Immuno North America business of Baxter Healthcare Corporation, having served in that capacity since 1998. Mr. Guiheen was responsible for Hemophilia and Immuno Globulin therapies as well as the launch of the first surgical fibrin sealant in the U.S. full biography >

CARL J. SCHRAMM
President and Chief Executive Officer, Ewing Marion Kauffman Foundation

Carl J. Schramm is president and chief executive officer of the Ewing Marion Kauffman Foundation. Previously, Schramm was chairman of Greenspring Advisors, Inc., a Baltimore-based merchant banking firm he founded to support business development in health care and insurance. In 1999 Schramm co-founded Patient Choice Health Care, Inc., in Minneapolis, where he serves as vice chairman of the board. Schramm has also served as the executive vice president of Fortis, Inc., where he oversaw health-care operations and was president of Fortis HealthCare. full biography >

Panelists & Moderators

• Faiz Kayyem, Vice President and General Manager, Clinical Micro Sensors, Inc., A Motorola Company
• Eric Donsky, Ocusense
• Ari Belldegrun, Agensys
• Scott Carter, Assistant Director, Caltech Office of Technology Transfer
• Andrew Neighbour, Associate Vice Chancellor for Research and Executive Director, UCLA
• Chuck Winn, Manager of Economic and Business Development, Southern California Edison
• Richard Morganstern, Executive Committee, Tech Coast Angels
• William Woodward, Managing Director and Founder, Anthem Venture Partners
• Jonah Schnel, Managing Partner, ITU Ventures
• Allen Sussman, Partner, Morrison & Foerster
• Mike Shockro, Partner, Latham and Watkins
• Alan Paau, Assistant Vice Chancellor, UCSD
• Vithal Rajadhyaksha, Associate Director, Health Sciences Office of Tech. Alliances, UCI
• William T. Frankenberger, Jr., Director, Center for Technology Development, UCR
• Klaus Brasch, Executive Director, Office of Research Development & Technology Transfer, CSUSB
• Randolph Hall, Associate Dean for Research, Industrial and Systems Engineering Department, University of Southern California
• Emily Loughran, Director of Licensing, Office of Intellectual Property of Administration, UCLA
• Sherylle Mills Englander, Director, Sponsored Projects and Intellectual Property, UCSB
• Jill Adler-Moore, California State Polytechnic University, Pomona
• Jeff Labovitz, President and CEO, Research and Education Institute at Harbor-UCLA Medical Center
• Daniel Morse, Director, Institute for Collaborative Biotechnologies
• Ken Polasko, Business Development Officer, UCLA

Who Should Attend?

• Executives and research directors of corporations seeking research collaborations and access to new technologies
• Startup company executives seeking licensing opportunities
• Venture capitalists and other investors seeking investment opportunities
• Faculty from Universities interested in entrepreneurship and commercialization
• Others in the technology community seeking to better understand how to work with research institutions (There will be opportunities for those in both life sciences and engineering/physical sciences fields)
  
  

Go online and Register Today!
http://www.Larta.org/t2/
Full price: $395
Full Time Students: $95